IndraLab
Statements
Liraglutide inhibits NLRP3. 27 / 27
|
27
reach
"“PINK/PARKIN” is referred to as a canonical mitophagy pathway.55 Evidence shows that Pink and Parkin protein levels are lowered in MASLD animal models, along with apoptosis, mitophagy blockade, and altered mitochondrial architecture.565758 Liraglutide has a solid track record of its protective effects against MASLD.5960 Yu et al found that liraglutide inhibited the production of ROS, exerted anti-inflammatory effects, reduced lipid accumulation, and inhibited the activation of NLRP3 inflammasome and cell pyroptosis by activating PINK expression, suggesting that liraglutide ameliorates MASLD by enhancing mitophagy."
reach
"The inhibition of mitophagy by 3-methyladenine (3-MA)/PINK1-directed siRNA dampened liraglutide suppression of NLRP3 inflammasome and pyroptosis activation, suggesting that liraglutide improved NASH by suppressing NLRP3 inflammasome and pyroptosis activation through promoting mitophagy [73]."
reach
"Liraglutide lowered NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in KCs and decreased mitochondrial dysfunction, leading to an important reduction in IL-1β, IL-12, and tumor necrosis factor-α (TNF-α) expression levels, while increasing the expression of IL-10 [47,48]."
| PMC